Privacy interests in prescription data, part I: Prescriber privacy

Abstract

For several years, concern has been growing about privacy implications that arise from using and disclosing prescription data. Some patterns or practices provide pharmaceutical companies with the historical trends they need to better target their marketing efforts aimed at individual physicians through more intense, precise, and unique detailing strategies. In the first of a two part-article, the authors focus the privacy implications arising from the sale or transfer of prescription data, in respect to prescribers in Canada and the US. // NOTE // This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All persons copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.